COMMUNIQUÉS West-GlobeNewswire

CV Sciences, Inc. Appoints Dr. Douglas MacKay as Senior Vice President of Scientific and Regulatory Affairs
01/03/2019
LAS VEGAS, March 01, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of industry-dominating hemp CBD brand, PlusCBD Oil [...]
Establishment Labs to Present at the Cowen 39th Annual Health Care Conference
01/03/2019
NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics [...]
MedTainer’s Record-Setting Pace Continues, Plans for Expansion Proceed
01/03/2019
CORONA, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- MedTainer Inc. (MDTR-OTCMARKETS) announced today that orders for its signature product, the MedTainer™, have continued to rise and the company has recorded the biggest [...]
Yield Growth’s Urban Juve Takes a Fresh Approach to Skincare-- CFN Media
01/03/2019
SEATTLE, March 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
Spero Therapeutics to Present at March Investor Conferences
01/03/2019
CAMBRIDGE, Mass., March 01, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]
Sanofi: CHMP recommends approval of Dupixent® (dupilumab) for asthma indication
01/03/2019
CHMP recommends approval of Dupixent ® (dupilumab) for asthma indication PARIS and TARRYTOWN, NY - March 1, 2019 - The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a [...]
Sanofi : Le CHMP recommande l'approbation de l'indication de Dupixent® (dupilumab) dans l'asthme
01/03/2019
Le CHMP recommande l'approbation de l'indication de Dupixent ® (dupilumab) dans l'asthme Paris et Tarrytown (New York) - Le 1 er mars 2019 - Le Comité des médicaments à usage humain (CHMP, Committee for Medicinal [...]
Portola Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
01/03/2019
– Fourth Quarter Andexxa ® Revenues of $14.0 Million; Third Consecutive Quarter of Strong Revenues – – Received Positive CHMP Opinion on Ondexxya™; European Commission Decision Anticipated in Early May – – Signed $125 [...]
Portola Pharmaceuticals Enters into $125 Million Loan Agreement with HealthCare Royalty Partners and Athyrium Capital Management
01/03/2019
Agreement Provides Financial Flexibility for the Ongoing Commercialization of Andexxa® and Launch Preparations in Europe SOUTH SAN FRANCISCO, Calif., March 01, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® ( [...]
Sanofi : CHMP recommends ZynquistaTM (sotagliflozin) for the treatment of adults with type 1 diabetes
01/03/2019
CHMP recommends ZynquistaTM (sotagliflozin) for the treatment of adults with type 1 diabetes PARIS and THE WOODLANDS, TX - March 1, 2019 - The European Medicines Agency's Committee for Medicinal Products for Human Use ( [...]
Sanofi : Le CHMP recommande ZynquistaTM (sotagliflozine) pour le traitement du diabète de type 1 chez l'adulte
01/03/2019
Le CHMP recommande ZynquistaTM (sotagliflozine) pour le traitement du diabète de type 1 chez l'adulte Paris et The Woodlands (Texas) - Le 1 er mars 2019 - Le Comité des médicaments à usage humain (CHMP, Committee for [...]
Celldex to Report Full Year 2018 Business/Financial Results and Host Corporate Update Call
01/03/2019
HAMPTON, N.J., March 01, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) will release fourth quarter and year-end 2018 financial results on Thursday, March 7, 2019 after the U.S. financial markets [...]
Krystal Biotech to Present at the Cowen and Company 39th Annual Health Care Conference
01/03/2019
PITTSBURGH, March 01, 2019 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin [...]
Zealand Pharma to attend Credit Suisse and BioCapital Healthcare Conferences
01/03/2019
Press release – No. 04 / 2019 Zealand Pharma to attend Credit Suisse and BioCapital Healthcare Conferences Copenhagen, March 1, 2019 – Adam Steensberg, Interim Chief Executive Officer, will attend the Credit Suisse 2019 [...]
Paratek Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference
01/03/2019
BOSTON, March 01, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]
Outlook Therapeutics Submits IND Application for ONS-5010 to the FDA
01/03/2019
CRANBURY, N.J., March 01, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the “Company”) announced today the submission of its Investigational New Drug (IND) application with the U.S. Food and Drug [...]
Principia Biopharma Presents Phase 1 Clinical Data from CNS Penetrating BTK Inhibitor Candidate PRN2246/SAR442168 at ACTRIMS 2019
01/03/2019
-- Orally administered PRN2246 achieved full BTK occupancy in peripheral blood -- -- PRN2246 exhibited blood-brain barrier permeability and CNS exposure -- -- Sanofi to lead Phase 2 development for people with Multiple [...]
Rexahn Pharmaceuticals Appoints Lara S. Sullivan to its Board of Directors
01/03/2019
ROCKVILLE, Md., March 01, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers [...]
Wellness Matrix Group To Initiate State-of-the-Art DNA Program
01/03/2019
LOS ANGELES, March 01, 2019 (GLOBE NEWSWIRE) -- Wellness Matrix Group, Inc. ( WMGR ), a technologically advanced Company in the Virtual Reality Artificial Intelligence health care model space, released details today on [...]

Pages